| SFDA Approved Use |
Ticagrelor co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with
- Acute coronary syndromes (ACS) or - A history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event. |
|---|
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.